{"name":"Omeros Corporation","slug":"omeros-corporation","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxOWFp0RVJoZ1ZETjZmVFF0R3ZMX001ZklKNFpIOVBYbEhXaUtKeVp3Z1ZVRC0wWnFHbVpteERCdmhnck1TRXVncXFrTm8tNjl4Z1otUkF6S1dfRHh2YzdPM0t6Z1d0X2pPTkpualptUV9Qd2M0SmZJZ2VDckJ6Vnl4WFh0eW1oYjE1WEhnd0QzbXhjc0NwVE1PVjVB?oc=5","date":"2026-01-08","type":"regulatory","source":"TechStock²","summary":"Omeros stock rises in premarket after $36,000-a-vial Yartemlea price is set - TechStock²","headline":"Omeros stock rises in premarket after $36,000-a-vial Yartemlea price is set - TechStock²","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxNQTVFdGQtUGRNQnZfN21sWHJrR2xYZ19GaEZNa2xXRUhseC0yTEVxcDJEa0ZtdnJ3SzZXeWN1TldabkQ5QnlpcU5ROEhTNDZieXhhOVdwcmlNYW43ZmlTQW1aRXdnSUdORm5Da0tsSzVPcVhsNFFldFBhcE9hcVgtV09HTmNSZTBtcnBKTW1lb2hVbjRoODZBNDZ0eXRfa1oxRE1lZl9fdnZtOXdUYTdjRm9sRQ?oc=5","date":"2025-12-26","type":"regulatory","source":"Fierce Pharma","summary":"Omeros scores its 1st FDA nod as stem cell transplant drug Yartemlea approved - Fierce Pharma","headline":"Omeros scores its 1st FDA nod as stem cell transplant drug Yartemlea approved","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxPaVlCY2RiNUYzTHItSVAtV3dvLU9fdDNsSW5UTEVHTURNMEVvT0d0M2U3NGFBeXFzaERCT05HbC1WemJKTVAyLVRYUTg1cDRMZXQyTjRqZjV1TFF2RUZ6MG1WMmFBZjI1cnhNSlI3Zm1FbHUwTTlIMVYzV3NPM3lpN0NZYUZ3ZVV2ZXBRMm5adFRrWDI2b243bloxdXhzN0NqSHFRNHZpb0pDT1A2cFZOWXN1N29VOTExUmJoYklHRkhycGdoMnQtd2o5Y3U4QVUweDR3V0Jn?oc=5","date":"2025-12-24","type":"regulatory","source":"Reuters","summary":"US FDA approves Omeros' drug to treat dangerous transplant complication - Reuters","headline":"US FDA approves Omeros' drug to treat dangerous transplant complication","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxOR21KVmYzMFBTdW1nLXFNRDlRVDhSMTNVWjlJc2cwV0FFam9ILUZrLXJ5WHNwV3BkaE8tYUNuQ1lBZm5QRHRvVkpZX3oyb1dzUWxybF83LUtIb0FZV3poTm9GUFV3OXBOaWk4VHBDQjVEaUNMTHQxRUhUb21TNG5kWmtINlJ3a2hKQTlR?oc=5","date":"2025-12-09","type":"earnings","source":"Yahoo Finance","summary":"Omeros Corporation's (NASDAQ:OMER) Shift From Loss To Profit - Yahoo Finance","headline":"Omeros Corporation's (NASDAQ:OMER) Shift From Loss To Profit","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxQWHlYQ1ZmOVROVS0zclN5SGVtRHkwbDdNMVFPa3hoTUtNYzRtd1AyZk9tUXFlWmNEZ0dvb21kWjdTTVhvUHNuRW5MYkZIUjJFTzMtVXpOOUcyT19tZkl0bFRkLXVBUHhiNnlBWkdnU0hDV3hjZ2FDaUFoaURxTFpKOGxUa3MyZjlBOFE?oc=5","date":"2025-10-22","type":"pipeline","source":"Yahoo Finance","summary":"Omeros Sells Exclusive Global Rights for Drug Zaltenibart to Novo Nordisk - Yahoo Finance","headline":"Omeros Sells Exclusive Global Rights for Drug Zaltenibart to Novo Nordisk","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-10-21","type":"pipeline","source":"medicaldialogues.in","summary":"Novo Nordisk inks pact with Omeros for clinical-stage MASP-3 inhibitor zaltenibart - medicaldialogues.in","headline":"Novo Nordisk inks pact with Omeros for clinical-stage MASP-3 inhibitor zaltenibart","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxNaUpKU3ZQemJIdjVGb3NUTXIzME1fUUVVbXJGNGkyTlhiTWw3SlZyZm1UYVhuMl96VVlmWXktcEVIOUlKS0RyUV9mZC1GNFVzVjQ4ejNhWENFWWUxdjBELXBlaXRBR0ZEY2c0UFdDOHBYTWFHeGMxekFIYm10RFl6Z1NNejdXSjJmTXFQUnpaczVXOU9tNGRZZk9fUlNkTHM?oc=5","date":"2025-10-16","type":"pipeline","source":"Pharmaceutical Technology","summary":"Novo Nordisk snaps up Omeros’ rare disease asset for up to $2.1bn - Pharmaceutical Technology","headline":"Novo Nordisk snaps up Omeros’ rare disease asset for up to $2.1bn","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxQdXpoblJNN0ZseGNoRXpvbHdIVjhRNUVnQS1OYnBZblNoT0lWY1h2RmVSdzJtMW1ud0E1SUFhSUFUVUpITThFZ3lhc2Y4ZkpaVW1fWDh2YTBnT1JBWmMwZ2VUVXdjYkE1QVBHbEV3T3dLbHpVbzg2NzZ4eGFRamYwNDcwUG9DSjZZelJ2RUhadHVzZElfc0hrdEJlNXFGcGZGbHBNSjVTbmxrSl9LSk1wSWV2b28yY3BMMWpsMkVDV1hONDk3S0NRRWdnZXZBZzdSRXRmeGx5REw?oc=5","date":"2025-10-16","type":"deal","source":"benefitsandpensionsmonitor.com","summary":"Novo Nordisk announces $2.9 billion Rare Disease acquisition deal with Omeros - benefitsandpensionsmonitor.com","headline":"Novo Nordisk announces $2.9 billion Rare Disease acquisition deal with Omeros","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxQX2JQS1owXzBpUkVvRHdwczJ6U1d1dTFOSUp4TFFCU21vcjREZ3c0MjVOMEZMZFRjUktoLTVXUlhYTmlZYjdkUHdOM2c0TFRiT0ZXQXBuWGhsb0N0MEdIdWloRHFjSkFyU0hHZ3ROWTA1OWF0YzlWU0FIY29kQ2hUYzA4UHpUVnRFQmcwSGlpeW9LZw?oc=5","date":"2025-10-15","type":"deal","source":"Fierce Biotech","summary":"Novo Nordisk pens $2.1B deal for Omeros’ stalled PNH drug - Fierce Biotech","headline":"Novo Nordisk pens $2.1B deal for Omeros’ stalled PNH drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNbEV0LVVEUlRMSW9TSzZkMGpJeHl0Q2VZVnlkWThFN3Q5aC1lQWp0MFFUOGFXems5cmw4cWl4enhQcmhQQXFJQkpsRGZvUXJrM1RZSHQ1X1hxQlJ5TEZxTnc0WjlXZGFqazZYRTA0Sm9xUkZUTWo4YnZBZFpxeDVVd3FLZE9RZ2Z3WVZ3bnVhdm05Zk1XRU9R?oc=5","date":"2025-10-15","type":"deal","source":"The Pharma Letter","summary":"Omeros rockets on news of deal with Novo Nordisk - The Pharma Letter","headline":"Omeros rockets on news of deal with Novo Nordisk","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQN2IyUV9qNjJtWWY1V3l1YURaOHpVSGZGV3dROE5ZcDdQRl9CZWNyQURfTFBvYmI0WDBEMUxvQ2FVSzlscF8wX2gzWG53dTRXVmxnWXpFSzFwRGpuX0VFV085UXk0NF9McEZ3RXJsZU5YT19RWW9tLVJXNEp2cWVmODJjbGFrbnVVUHpobGh6Y3JSbThpV2pvTFhKbUI1MTZPQlhz?oc=5","date":"2025-10-15","type":"deal","source":"The Business Journals","summary":"Seattle company inks up to $2.1 billion deal with pharma giant - The Business Journals","headline":"Seattle company inks up to $2.1 billion deal with pharma giant","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxOOXBHYTMwTDROcTNNVExYajJGeVZocmlYX2dsNWVIOG5VcXN1OVVwQ25OcUZUajVjYzFZMFBYcVZWYVV3WXB2ZWU0d1FCazdta19vZWN6WnJhUnlrdzdOemF4cE9GaXZhZ2dZY1l6Y0hROXV6NzZKc3EySWlxR01FR1pNZTVINlEwOVBZOEZkVXNRREFUYkpGN29Ua3kzeWZYLS1SZW9fYnNMNTRDUTJpRU8wMG1YQ3pkVE5YUjNJSWlwY0F1Wl8yd0lESUFEcDMyZHRxYXNOblJtbGlMclVCa0xWUQ?oc=5","date":"2025-10-15","type":"deal","source":"Reuters","summary":"Novo Nordisk signs up to $2.1 billion licensing deal with Omeros in rare disease push - Reuters","headline":"Novo Nordisk signs up to $2.1 billion licensing deal with Omeros in rare disease push","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}